C W Davis - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

C W Davis

Showing results (81-90 of 82) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 82 results.

The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002

Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosisB R Yerxa, J R Sabater, C W Davis, et al.

COPD|February 5, 2019

Mucus Hydration in Subjects with Stable Chronic Bronchitis: A Comparison of Spontaneous and Induced SputumAshley G Henderson, Wayne H Anderson, Agathe Ceppe, et al.

Pageof 9

Search research articles

Showing results (81-90 of 82) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 82 results.

The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002

Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosisB R Yerxa, J R Sabater, C W Davis, et al.

COPD|February 5, 2019

Mucus Hydration in Subjects with Stable Chronic Bronchitis: A Comparison of Spontaneous and Induced SputumAshley G Henderson, Wayne H Anderson, Agathe Ceppe, et al.

Pageof 9